CLPTM1L induces estrogen receptor β signaling-mediated radioresistance in non-small cell lung cancer cells

[1]  Jing Lin,et al.  Elevation of long non-coding RNA GAS5 and knockdown of microRNA-21 up-regulate RECK expression to enhance esophageal squamous cell carcinoma cell radio-sensitivity after radiotherapy. , 2019, Genomics.

[2]  Zhuo Wang,et al.  Estrogen receptors promote NSCLC progression by modulating the membrane receptor signaling network: a systems biology perspective , 2019, Journal of Translational Medicine.

[3]  H. Morgenstern,et al.  Lung Cancer Risk in Never-Smokers of European Descent is Associated With Genetic Variation in the 5p15.33 TERT-CLPTM1Ll Region. , 2019, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

[4]  K. Steele,et al.  Automated image analysis of NSCLC biopsies to predict response to anti-PD-L1 therapy , 2019, Journal of Immunotherapy for Cancer.

[5]  Saijun Fan,et al.  MiR-365 enhances the radiosensitivity of non-small cell lung cancer cells through targeting CDC25A. , 2019, Biochemical and biophysical research communications.

[6]  F. Ciardiello,et al.  Activity and molecular targets of pioglitazone via blockade of proliferation, invasiveness and bioenergetics in human NSCLC , 2019, Journal of Experimental & Clinical Cancer Research.

[7]  Q. Song,et al.  Radiotherapy for oligometastatic tumor improved the prognosis of patients with non‐small cell lung cancer (NSCLC) , 2019, Thoracic cancer.

[8]  Jacquelyn O. Russell,et al.  Hepatocyte‐Specific β‐catenin Deletion During Severe Liver Injury Provokes Cholangiocytes to Differentiate into Hepatocytes , 2019, The FASEB Journal.

[9]  S. Bekiranov,et al.  NF-κB upregulates glutamine-fructose-6-phosphate transaminase 2 to promote migration in non-small cell lung cancer , 2019, Cell Communication and Signaling.

[10]  L. Amundadottir,et al.  CLPTM1L/CRR9 ectodomain interaction with GRP78 at the cell surface signals for survival and chemoresistance upon ER stress in pancreatic adenocarcinoma cells , 2019, International journal of cancer.

[11]  S. Forbes,et al.  Hepatocyte‐Specific β‐Catenin Deletion During Severe Liver Injury Provokes Cholangiocytes to Differentiate Into Hepatocytes , 2019, Hepatology.

[12]  Rolando Garcia-Milian,et al.  Estrogen receptor-alpha isoforms are the main estrogen receptors expressed in non-small cell lung carcinoma , 2018, Steroids.

[13]  Endi Wang,et al.  X-ray irradiation induced Disabled-2 gene promoter de-methylation enhances radiosensitivity of non-small-cell lung carcinoma cells , 2018, Journal of experimental & clinical cancer research : CR.

[14]  J. F. Burrows,et al.  USP17 is required for trafficking and oncogenic signaling of mutant EGFR in NSCLC cells , 2018, Cell Communication and Signaling.

[15]  S. Yeh,et al.  Estrogen receptor β promotes the vasculogenic mimicry (VM) and cell invasion via altering the lncRNA-MALAT1/miR-145-5p/NEDD9 signals in lung cancer , 2018, Oncogene.

[16]  Xiao Wei,et al.  17β-estradiol upregulates IL6 expression through the ERβ pathway to promote lung adenocarcinoma progression , 2018, Journal of Experimental & Clinical Cancer Research.

[17]  Wuwu Lv,et al.  miR-495 enhances the efficacy of radiotherapy by targeting GRP78 to regulate EMT in nasopharyngeal carcinoma cells , 2018, Oncology reports.

[18]  W. Bshara,et al.  Smoking, Sex, and Non–Small Cell Lung Cancer: Steroid Hormone Receptors in Tumor Tissue (S0424) , 2018, Journal of the National Cancer Institute.

[19]  Hongbing Shen,et al.  Fine mapping in TERT‐CLPTM1L region identified three independent lung cancer susceptibility signals: A large‐scale multi‐ethnic population study , 2018, Molecular carcinogenesis.

[20]  Li Zhong,et al.  rs401681 and rs402710 confer lung cancer susceptibility by regulating TERT expression instead of CLPTM1L in East Asian populations , 2018, Carcinogenesis.

[21]  K. Luo,et al.  The lncRNA MIR4435-2HG promotes lung cancer progression by activating β-catenin signalling , 2018, Journal of Molecular Medicine.

[22]  N. Liang,et al.  Estrogen‐related receptor alpha triggers the proliferation and migration of human non‐small cell lung cancer via interleukin‐6 , 2018, Cell biochemistry and function.

[23]  J. Dai,et al.  A fast optimization approach for treatment planning of volumetric modulated arc therapy , 2018, Radiation Oncology.

[24]  A. Chande,et al.  Catalytic Enantioselective 1,3-Alkyl Shift in Alkyl Aryl Ethers: Efficient Synthesis of Optically Active 3,3'-Diaryloxindoles. , 2018, Angewandte Chemie.

[25]  M. Young,et al.  Timeless Is a Novel Estrogen Receptor Co-activator Involved in Multiple Signaling Pathways in MCF-7 Cells. , 2018, Journal of molecular biology.

[26]  J. Willmann,et al.  Intraoperative Resection Guidance with Photoacoustic and Fluorescence Molecular Imaging Using an Anti–B7-H3 Antibody-Indocyanine Green Dual Contrast Agent , 2018, Clinical Cancer Research.

[27]  O. Brustugun,et al.  Expression of Estrogen Receptor-α and Survival in Advanced-stage Non-small Cell Lung Cancer. , 2018, Anticancer research.

[28]  J. Zhou,et al.  Activation of PPARα by clofibrate sensitizes pancreatic cancer cells to radiation through the Wnt/β-catenin pathway , 2018, Oncogene.

[29]  B. Hui,et al.  Effect of sinomenine hydrochloride on radiosensitivity of esophageal squamous cell carcinoma cells , 2018, Oncology reports.

[30]  Xiaoting Zhang,et al.  HER2-Driven Breast Tumorigenesis Relies upon Interactions of the Estrogen Receptor with Coactivator MED1. , 2018, Cancer research.

[31]  N. M. Glykos,et al.  Folding Simulations of a Nuclear Receptor Box-Containing Peptide Demonstrate the Structural Persistence of the LxxLL Motif Even in the Absence of Its Cognate Receptor. , 2018, The journal of physical chemistry. B.

[32]  Jürgen Debus,et al.  Oncogene addiction and radiation oncology: effect of radiotherapy with photons and carbon ions in ALK-EML4 translocated NSCLC , 2018, Radiation Oncology.

[33]  Astrid Zimmermann,et al.  Overcoming hypoxia-induced tumor radioresistance in non-small cell lung cancer by targeting DNA-dependent protein kinase in combination with carbon ion irradiation , 2017, Radiation Oncology.

[34]  J. Gustafsson,et al.  ERβ Sensitizes NSCLC to Chemotherapy by Regulating DNA Damage Response , 2017, Molecular Cancer Research.

[35]  V. Brower.  Adding radiotherapy to chemotherapy in advanced NSCLC. , 2017, The Lancet. Oncology.

[36]  Jae-Ho Lee,et al.  A TERT-CLPTM1 locus polymorphism (rs401681) is associated with EGFR mutation in non-small cell lung cancer. , 2017, Pathology, research and practice.

[37]  Harini Krishnan,et al.  Estrogen Receptor α- and β-Interacting Proteins Contain Consensus Secondary Structures: An Insilico Study , 2017, Annals of Neurosciences.

[38]  Hyoung-Tae Kim,et al.  Degradation of Bcl-2 by XIAP and ARTS Promotes Apoptosis. , 2017, Cell reports.

[39]  L. Milanesi,et al.  The nuclear receptor ERβ engages AGO2 in regulation of gene transcription, RNA splicing and RISC loading , 2017, Genome Biology.

[40]  Jason Gertz,et al.  Clinical and genomic crosstalk between glucocorticoid receptor and estrogen receptor α in endometrial cancer , 2017, bioRxiv.

[41]  Y. Miller,et al.  Clinical Utility of Chromosomal Aneusomy in Individuals at High Risk of Lung Cancer , 2017, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

[42]  W. Chiu,et al.  Structural and Functional Impacts of ER Coactivator Sequential Recruitment. , 2017, Molecular cell.

[43]  Lin Chen,et al.  Systemic analysis of different colorectal cancer cell lines and TCGA datasets identified IGF-1R/EGFR-PPAR-CASPASE axis as important indicator for radiotherapy sensitivity. , 2017, Gene.

[44]  Hongbing Shen,et al.  Fine mapping of chromosome 5p15.33 identifies novel lung cancer susceptibility loci in Han Chinese , 2017, International journal of cancer.

[45]  Q. Fu,et al.  miRomics and Proteomics Reveal a miR-296-3p/PRKCA/FAK/Ras/c-Myc Feedback Loop Modulated by HDGF/DDX5/β-catenin Complex in Lung Adenocarcinoma , 2017, Clinical Cancer Research.

[46]  Conor K McGarry,et al.  Inhibition of ataxia telangiectasia related-3 (ATR) improves therapeutic index in preclinical models of non-small cell lung cancer (NSCLC) radiotherapy. , 2017, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[47]  T. Efstathiou,et al.  Glyceollins trigger anti-proliferative effects through estradiol-dependent and independent pathways in breast cancer cells , 2017, Cell Communication and Signaling.

[48]  Carl-Magnus Clausson,et al.  Insufficient antibody validation challenges oestrogen receptor beta research , 2017, Nature Communications.

[49]  Zhi-rui Zhou,et al.  Estrogen Receptor Mediates the Radiosensitivity of Triple-Negative Breast Cancer Cells , 2017, Medical science monitor : international medical journal of experimental and clinical research.

[50]  H. Ditzel,et al.  Co-activation of STAT3 and YES-Associated Protein 1 (YAP1) Pathway in EGFR-Mutant NSCLC , 2017, Journal of the National Cancer Institute.

[51]  D. Cox,et al.  A GWAS in uveal melanoma identifies risk polymorphisms in the CLPTM1L locus , 2017, npj Genomic Medicine.

[52]  J. Hartman,et al.  Estrogen Receptor β as a Therapeutic Target in Breast Cancer Stem Cells , 2017, Journal of the National Cancer Institute.

[53]  O. Kallioniemi,et al.  Cell of Origin Links Histotype Spectrum to Immune Microenvironment Diversity in Non-small-Cell Lung Cancer Driven by Mutant Kras and Loss of Lkb1. , 2017, Cell reports.

[54]  Xiang Wang,et al.  miR-21-mediated Radioresistance Occurs via Promoting Repair of DNA Double Strand Breaks* , 2017, The Journal of Biological Chemistry.

[55]  P. Wei,et al.  Mitochondrial PKM2 regulates oxidative stress-induced apoptosis by stabilizing Bcl2 , 2016, Cell Research.

[56]  Tangchun Wu,et al.  The associations of TERT-CLPTM1L variants and TERT mRNA expression with the prognosis of early stage non-small cell lung cancer , 2016, Cancer Gene Therapy.

[57]  Shin Jung,et al.  Enhancement of radiosensitivity by inhibition of c-Jun N-terminal kinase activity in a Lewis lung carcinoma‑bearing subcutaneous tumor mouse model. , 2016, Oncology reports.

[58]  E. Richardsen,et al.  Prognostic relevance of estrogen receptor α, β and aromatase expression in non-small cell lung cancer , 2016, Steroids.

[59]  N. Yu,et al.  Roles of ERα and ERβ in estrogen-induced DDP chemoresistance in non-small cell lung cancer. , 2016, Genetics and molecular research : GMR.

[60]  Hyun-Jin Kang,et al.  Correction to “The Dynamic Character of the BCL2 Promoter i-Motif Provides a Mechanism for Modulation of Gene Expression by Compounds That Bind Selectively to the Alternative DNA Hairpin Structure” , 2016, Journal of the American Chemical Society.

[61]  Geoffrey Liu,et al.  Systematic Review of Genetic Variation in Chromosome 5p15.33 and Telomere Length as Predictive and Prognostic Biomarkers for Lung Cancer , 2016, Cancer Epidemiology, Biomarkers & Prevention.

[62]  Z. Du,et al.  Functional evaluation of TERT-CLPTM1L genetic variants associated with susceptibility of papillary thyroid carcinoma , 2016, Scientific Reports.

[63]  Qingqing Zhu,et al.  Prognostic value of the expression of estrogen receptor β in patients with non-small cell lung cancer: a meta-analysis. , 2016, Translational lung cancer research.

[64]  Y. Matsumoto,et al.  LIG4 mediates Wnt signalling-induced radioresistance , 2016, Nature Communications.

[65]  S. Jun,et al.  Inhibitory effect of traditional oriental medicine-derived monoamine oxidase B inhibitor on radioresistance of non-small cell lung cancer , 2016, Scientific Reports.

[66]  L. Kang,et al.  CLPTM1L polymorphism as a protective factor for lung cancer: a case–control study in southern Chinese population , 2016, Tumor Biology.

[67]  Xuming Luo,et al.  Prognostic significance of CLPTM1L expression and its effects on migration and invasion of human lung cancer cells. , 2016, Cancer biomarkers : section A of Disease markers.

[68]  L. Tse,et al.  Prognostic value of estrogen receptors mRNA expression in non-small cell lung cancer: A systematic review and meta-analysis , 2015, Steroids.

[69]  Z. Cai,et al.  Rs401681 polymorphism in TERT-CLPTM1L was associated with bladder cancer risk: A meta-analysis , 2015, Iranian journal of basic medical sciences.

[70]  K. Dahlman-Wright,et al.  Estrogen receptor alpha and beta in health and disease. , 2015, Best practice & research. Clinical endocrinology & metabolism.

[71]  Shuhang Wang,et al.  ERβ localization influenced outcomes of EGFR-TKI treatment in NSCLC patients with EGFR mutations , 2015, Scientific Reports.

[72]  K. Horie-Inoue,et al.  Identification of estrogen-responsive genes based on the DNA binding properties of estrogen receptors using high-throughput sequencing technology , 2014, Acta Pharmacologica Sinica.

[73]  Hong Wang,et al.  CLPTM1L Genetic Polymorphisms and Interaction With Smoking and Alcohol Drinking in Lung Cancer Risk , 2014, Medicine.

[74]  K. Ang,et al.  miR-205 acts as a tumor radiosensitizer by targeting ZEB1 and Ubc13 , 2014, Nature Communications.

[75]  Sheng Zhou,et al.  Fulvestrant-Mediated Inhibition of Estrogen Receptor Signaling Slows Lung Cancer Progression , 2014, Oncology research.

[76]  W. Lim,et al.  Serum estrogen receptor beta mediated bioactivity correlates with poor outcome in lung cancer patients. , 2014, Lung cancer.

[77]  William Wheeler,et al.  Imputation and subset-based association analysis across different cancer types identifies multiple independent risk loci in the TERT-CLPTM1L region on chromosome 5p15.33. , 2014, Human molecular genetics.

[78]  M. Tsao,et al.  A genetic sequence variant (GSV) at susceptibility loci of 5p15.33 (TERT-CLPTM1L) is associated with survival outcome in locally advanced and metastatic non-small-cell lung cancer (NSCLC). , 2014, Lung cancer.

[79]  Baosen Zhou,et al.  Genetic polymorphisms of TERT and CLPTM1L and risk of lung cancer: a case–control study in northeast Chinese male population , 2014, Medical Oncology.

[80]  S. Thorgeirsson,et al.  CLPTM1L promotes growth and enhances aneuploidy in pancreatic cancer cells. , 2014, Cancer research.

[81]  Hyun-Jin Kang,et al.  The Dynamic Character of the BCL2 Promoter i-Motif Provides a Mechanism for Modulation of Gene Expression by Compounds That Bind Selectively to the Alternative DNA Hairpin Structure , 2014, Journal of the American Chemical Society.

[82]  M. You,et al.  Crr9/clptm1l Regulates Cell Survival Signaling and Is Required for Ras Transformation and Lung Tumorigenesis Figures: 7 Main Text and 7 Supplementary , 2022 .

[83]  Baosen Zhou,et al.  Genetic variations in TERT-CLPTM1L genes and risk of lung cancer in a Chinese population. , 2014, Asian Pacific journal of cancer prevention : APJCP.

[84]  F. Sarkar,et al.  DIM (3,3′-diindolylmethane) confers protection against ionizing radiation by a unique mechanism , 2013, Proceedings of the National Academy of Sciences.

[85]  Sandra A O'Toole,et al.  Molecular biology of lung cancer. , 2013, Journal of thoracic disease.

[86]  Yong-Jun Zhang,et al.  No association of XRCC1 and CLPTM1L polymorphisms with non-small cell lung cancer in a non-smoking Han Chinese population. , 2013, Asian Pacific journal of cancer prevention : APJCP.

[87]  Yu Zhao,et al.  The oncoprotein HBXIP upregulates Lin28B via activating TF II D to promote proliferation of breast cancer cells , 2013, International journal of cancer.

[88]  Peter Kraft,et al.  Fine-mapping identifies multiple prostate cancer risk loci at 5p15, one of which associates with TERT expression , 2013, Human molecular genetics.

[89]  Chawnshang Chang,et al.  Testicular orphan nuclear receptor 4-associated protein 16 promotes non-small cell lung carcinoma by activating estrogen receptor β and blocking testicular orphan nuclear receptor 2 , 2012, Oncology reports.

[90]  Zonghai Li,et al.  The synergistic effect of EGFR tyrosine kinase inhibitor gefitinib in combination with aromatase inhibitor anastrozole in non-small cell lung cancer cell lines. , 2012, Lung cancer.

[91]  H. Nguyen,et al.  Estrogen receptor α/β-cofactor motif interactions; interplay of tyrosine 537/488 phosphorylation and LXXLL motifs. , 2012, Molecular bioSystems.

[92]  Hongbing Shen,et al.  Common genetic variants in TERT contribute to risk of cervical cancer in a Chinese population , 2012, Molecular carcinogenesis.

[93]  Sichun Yang,et al.  Identification of a Novel LXXLL Motif in α-Actinin 4-spliced Isoform That Is Critical for Its Interaction with Estrogen Receptor α and Co-activators* , 2012, The Journal of Biological Chemistry.

[94]  J. Xiang,et al.  Enhanced radiosensitivity of non-small-cell lung cancer (NSCLC) by adenovirus-mediated ING4 gene therapy , 2012, Cancer Gene Therapy.

[95]  H. Sasano,et al.  Cytoplasmic estrogen receptor β as a potential marker in human non-small cell lung carcinoma , 2012, Expert opinion on therapeutic targets.

[96]  A. Cheng,et al.  Overexpression of HMGA1 deregulates tumor growth via cdc25A and alters migration/invasion through a cdc25A-independent pathway in medulloblastoma , 2012, Acta Neuropathologica.

[97]  Jane E. Carpenter,et al.  A common variant at the TERT-CLPTM1L locus is associated with estrogen receptor–negative breast cancer , 2011, Nature Genetics.

[98]  K. Lu,et al.  Estrogen receptor β signaling regulates the progression of Chinese non-small cell lung cancer , 2011, The Journal of Steroid Biochemistry and Molecular Biology.

[99]  Z. Szallasi,et al.  An online survival analysis tool to rapidly assess the effect of 22,277 genes on breast cancer prognosis using microarray data of 1,809 patients , 2010, Breast Cancer Research and Treatment.

[100]  Hilde van der Togt,et al.  Publisher's Note , 2003, J. Netw. Comput. Appl..

[101]  J. Seo,et al.  Retinoic Acid as a Radiosensitizer on the Head and Neck Squamous Cell Carcinoma Cell Lines. , 2001, Cancer research and treatment : official journal of Korean Cancer Association.

[102]  A. Okamoto,et al.  A novel gene, CRR9, which was up-regulated in CDDP-resistant ovarian tumor cell line, was associated with apoptosis. , 2001, Biochemical and biophysical research communications.

[103]  G. Stancel,et al.  Identification of an estrogen response element in the 3'-flanking region of the murine c-fos protooncogene. , 1992, The Journal of biological chemistry.